Cortellis Competitive Intelligence

The Cortellis Competitive Intelligence MCP connector gives AI assistants structured access to global biopharma intelligence for competitive analysis, asset tracking, and research workflows. It helps teams move from a natural-language question to evidence-led answers grounded in Cortellis Competitive Intelligence data, without leaving the AI environment where they plan, analyze, and communicate.

The connector supports research across the full drug-development lifecycle, from early research through commercialization. Users can investigate drugs, companies, therapeutic areas, clinical trials, patents, regulatory activity, deals, news, and market signals; then bring the relevant findings into product strategy, business-development, portfolio, medical-affairs, and competitive-intelligence workflows.

Cortellis Competitive Intelligence is built from sources that matter most for biopharma analysis: press releases, seven major global patent offices, ClinicalTrials.gov and other trial sources, company pipelines and presentations, 100+ scientific and medical conferences, annual reports, SEC filings, broker research, major regulatory agencies including FDA, EMA, PMDA, and TGA, and 700+ peer-reviewed journals.